user-generated· product
UK obesity drug market value exceeds £2B by December 2026
With Wegovy's pill launch expanding access and demand for semaglutide-based treatments, total UK obesity drug market revenue will surpass £2 billion by December 2026. This includes both injection and oral forms, driven by private prescriptions and NHS adoption pressure.
product · Prediction Market
- Implied probability (Yes)
- 70%
- Closes
- 2026-12-31
More product markets
- Vercel’s Eve framework adoption exceeds 50% among enterprise AI deployments by Dec 2026 — 70% Yes
- OpenAI will delay its 2026 hardware launch due to Apple lawsuit — 55% Yes
- Netflix to introduce micro-episode format by December 2026 — 68% Yes
- Govee Glide Hexa Light Panels will see a 30% increase in sales by Q4 2026 — 70% Yes
- Coinbase launches new staking product by August 2026 — 55% Yes
- Competitor AI models adopt 'J-Space'-like reasoning by 2027-03-31 — 60% Yes
- Tesla partners with Sadi Thermal Machines for next-gen heat pump tech — 60% Yes
- Claude's J-Space adoption accelerates in enterprise AI tools — 70% Yes
Loading…